Candra Cahyaningtyas Giyanto 22010111130090 Lap.KTI BAB VIII

(1)

65

1. Vitoratos N, Vrachnis N, Iavazzo C, Kyorgiou M. Preeclampsia: molecular

mechanisms, predisposition, and treatment. Journal of Pregnancy[Internet].

2012

[cited

2014

Nov

18].

Available

from

:

http://dx.doi.org/10.1155/2012/145487.

2. Guerrier G, Oluyide B, Keramarou M, Grais RF. Factors associated with

severe preeclampsiaand eclampsia in Jahun, Nigeria. International Journal of

Women’s Health. 2013; 5; 509

-513.

3. Cunningham FG, Levenno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY.

Hipertensi dalam kehamilan. In : Pendit BU, Setia R, editor. Obstetri

williams. 23

th

ed. Jakarta : Penerbit Buku Kedokteran EGC; 2013 : 740-794.

4. Backes CH, Markham K, Moorehead P, Cordero L, Nankervis CA, Giannone

PJ. Maternal preeclampsia and neonatal outcomes. Journal of Pregnancy

[Internet].

2011

[cited

2014

Nov

25].

Available

from

:

http://dx.doi.org/10.1155/2011/214365.

5. Membedah angka kematian ibu : penyebab dan akar masalah tingginya angka

kematian ibu. Konferensi INFID; 2013 November 26-27. Jakarta; 2014.

6. Widiyanto. Kehamilan dengan preeklampsia berat [thesis]. Semarang: Bagian

Obstestri dan Ginekologi Fakultas Kedokteran Universitas Diponegoro; 2005.

7. Manuaba IBG, Manuaba IAC, Manuaba IBGF. Hipertensi dalam kehamilan.

In : Astuti NZ, Purba DI, Handayani S, Damayanti R, editor. Pengantar

(2)

8. DeCherney AH, Nathan L. Hypertensive states of pregnancy. In : Current

obstetric and gynecologic diagnosis and treatment. 9

th

ed. New York :

McGRAW-HILL Inc; 2003.

9. Canzoneri BJ, Lewis DF, Groome L, Wang Y. Increased neutrophil number

account for leukocytosis in women with preeclampsia. American Journal of

Perinatology. 2011.

10. Gana YY. Hubungan kadar hematokrit dengan derajat preeklampsia.

Surakarta : Fakultas Kedokteran Universitas Sebelas Maret; 2010.

11. Yusrianty D, Lukas E, Tahir M. Kadar serum P38 MAPK, profil darah pada

pasien preeklampsia berat dibandingkan kehamilan normal. JST Kesehatan.

2014; 4(3): 291-298.

12. Adhie RP. Hubungan antara kadar hematokrit dan trombosit maternal

terhadap keluaran perinatal pada eklampsia berat [thesis]. Semarang : Bagian

Obstetri dan Ginekologi Fakultas Kedokteran Universitas Diponegoro; 2004.

13. Kawuryan SL. Pengaruh kadar trombosit, hematokrit, hemoglobin darah dan

protein urin pada ibu preeklampsia/eklampsia terhadap nilai apgar bayi yang

dilahirkan. Jurnal Kedokteran Brawijaya. 2004; 20(2): 78-81.

14. Poon LC, Nicolaides KH. Early prediction of preeclampsia. Obstetrics and

Gynecology International[Internet]. 2014 [cited 2014 Nov 17]. Available

from : http://dx.doi.org/10.1155/2014/297397

15. Moura SAMH, Lopes LM, Murthi P, Costa FS. Prevention of preeclampsia.

Journal of Pregnancy[Internet]. 2012 [cited 2014 Nov 17]. Available from :

(3)

16. Angsar MD. Hipertensi dalam kehamilan. In : Saifuddin AB, Rachimhadhi T,

Wiknjosastro GH, editor. Ilmu kebidanan sarwono prawirohardjo. Edisi

keempat. Jakarta : Bina Pustaka Sarwono Prawirohadjo; 2011.

17. Birawa AD, Hadisaputro H, Hadijono S. Kadar d-dimer pada ibu hamil

dengan preeklampsia berat dan normotensi di rsup dr. kariadi. Majalah

Obstetri Ginekologi Indonesia. 2009; 33(2): 65-78.

18. Diagnosis and management of preeclampsia and eclampsia. ACOC Practice

Bulletin: Clinical Management Guideline for Obstetrician-Gynecologists.

2002; 33.

19. Vanderlelie J. Placental oxidative stress in preeclampsia[thesis]. Brisbane:

Griffith University; 2005.

20. Powe CE, Levine RJ, Karumanchi A. Preeclampsia, a disease of the maternal

endothelium : the role of antiangiogenic factors and implications for later

cardiovascular disease. American Heart Association Journals. 2014.

21. Indrianto A, Hadisaputro H. Preeklampsia berat di RS Dr. Kariadi periode 1

januari 2004

–

31 desember 2004[thesis]. Semarang: Bagian Obstestri dan

Ginekologi Fakultas Kedokteran Universitas Diponegoro; 2009.

22. Nugroho T. Patologi kebidanan. Yogyakarta: Nuha Medika; 2012: 1-12.

23. Nankali A, Malek-khosravi S, Zangeneh M, Rezaei M, Hemati Z, Kohzadi

M. Maternal complication associated with severe preeclampsia. The Journal

(4)

24. Eiland E, Nzerue C, Faulkner M. Preeclampsia 2012. Journal of

Pregnancy[internet].

2012[cited

2015

Jan

19].

Availabel

from:

http://dx.doi.org/10.1155/2012/586578.

25. Sacher RA, McPherson RA. Widmann’s clinical interpretation of laboratory

test. In : Brahm U, Wulandari D, Hartanto H. Tinjauan klinis hasil

pemeriksaan laboratorium. 11

th

ed. Jakarta : Penerbit Buku Kedokteran EGC;

2004 : 21-66.

26. Tarwoto, Watonah. Keperawatan medikal bedah: gangguan sistem

hematologi. Jakarta : Trans Info Media; 2008: 9-29.

27. Gandasoebrata R. Penuntun laboratorium klinik. Jakarta : Dian Rakyat; 2007:

11-14.

28. Sutedjo AY. Buku saku mengenal penyakit melalui hasil pemeriksaan

laboratorium. Yogyakarta : Penerbit Amara Books; 2009: 17-35.

29. EffendiZ. Peranan leukosit sebagai anti inflamasi alergik dalam

tubuh[internet].

2003[cited

2015

Jan

31].

Availabel

from:

library.usu.ac.id/download/fk/histologi-zukesti2.pdf.

30. Mudita IB. Sel darah putih: gangguan fungsi granulosit dan granulopoiesis. In

: Permono HB, Sutaryo, Ugrasena IGD, Windiastuti E, Abdulsalam M. Buku

ajar hematologi-onkologi anak. Jakarta : Badan Penerbit IDAI, 2012:

101-132.

31. Kee JL. Laboratory and diagnostic tests with nursing implication. In :

(5)

pemeriksaan laboratorium dan diagnostik. 6

th

ed. Jakarta: Penerbit Buku

Kedokteran EGC; 2003: 479-482.

32. Onisai M, Vladareanu A, Bumbea H, Ciorascu M, Pop C, Andrei C, et al. A

study of hematologycal picture and of platelet function in preeclampsia.

Maedica : A Journal of Clinical Medicine. 2009; 4(4): 327-337.

33. Sabatier F, Bretelle F, d’Ercole C, Boubli L, Sampol J, Dignat

-George F.

Neutrophil activation in preeclampsia and isolated intrauterine growth

restriction. American Journals of Obstetric and Gynecology. 2000; 183(6) :

1558-1563.

34. Mihu D, Sabau L, Costin N, Ciortea R, Oancea M, Malutan A. Evaluation of

leukocytes and neutrophils, markers of inflammatory syndrome in

preeclampsia. Applied Medical Informatics. 2010; 27(3) : 15-22.

35. Raras AA. Pengaruh preeklampsia berat pada kehamilan terhadap keluaran

maternal dan perinatal di RSUP Dr. Kariadi tahun 2010. Semarang : Fakultas

Kedokteran Universitas Diponegoro; 2011.

36. Konimusliha P. Hubungan antara frekuensi pelayanan antenatal dengan

kejadian preeklampsia berat : studi kasus di RSUP Dr. Kariadi tahun 2010.

Semarang : Fakultas Kedokteran Universitas Diponegoro; 2011.

37. Kuriakose P. Anemia: an approach to evaluation, 2014. CHRISMED Journal

of Health and Research [internet]. 2015; 2(2) : 95-99 [cited 17 Jun 2015].

Availabel

from

:

(6)

38. Monteiro G, Subbalakshmi, Pai SR. Revelance of measurement of

hematological parameters in subjects with pregnancy induced hypertention.

Nitte University Journal of Health Science. 2014; 4(1) : 15-20.

39. Yang SW, Cho SH, Kwon HS, Sohn IS, Hwang HS. Significance of the

platelet distribution width as a severity marker for the development of

preeclampsia. European Journal of Obstetrics & Gynecology and

Reproductive Biology. 2014; 175 : 107-111.

40. Selamat, Aditiawarman. Clinical and laboratory profiles relationships of

preeclampsia-eclampsia patients with maternal mortality in Dr. Soetomo

hospital, Surabaya. Majalah Obstetri & Ginekologi. 2012; 20 (1) : 35-39.

41. Jwa SC, Fujiwara T, Yamanobe Y, Kozuka K, Sago H.Changes in maternal

hemoglobin during pregnancy and birth outcomes. BMC Pregnancy and

(7)

(8)

(9)

Lampiran 3. Hasil

Output SPSS

Deskripsi Usia Pasien Preeklampsia

Statistic Std. Error

Usia

Mean 29,05 ,770

95% Confidence Interval for

Mean

Lower Bound 27,52

Upper Bound 30,58

5% Trimmed Mean 28,91

Median 28,00

Variance 50,379

Std. Deviation 7,098

Minimum 16

Maximum 48

Range 32

Interquartile Range 12

Skewness ,253 ,261

Kurtosis -,718 ,517

Deskripsi Usia Kelompok Kontrol

Usia

Mean 27,88 ,658

Mean

Lower Bound 26,57

Upper Bound 29,19

Median 28,00

Variance 36,819

Minimum 15

Maximum 47

Range 32

Skewness ,251 ,261

(10)

Frekuensi Usia Preeklampsia Ringan

Frequency Percent Valid Percent Cumulative Percent

Valid

<20 tahun 1 7,7 7,7 7,7

20-35 tahun 9 69,2 69,2 76,9

>35 tahun 3 23,1 23,1 100,0

Total 13 100,0 100,0

Frekuensi Usia Preeklampsia Berat

Valid

<20 tahun 2 12,5 12,5 12,5 20-35 tahun 12 75,0 75,0 87,5 >35 tahun 2 12,5 12,5 100,0

Total 16 100,0 100,0

Frekuensi Usia Kelompok Kontrol

Frekuensi Alamat Preeklampsia Ringan

Valid

Semarang 12 92,3 92,3 92,3

Luar Semarang 1 7,7 7,7 100,0

Total 13 100,0 100,0

Frekuensi Alamat Preeklampsia Berat

Valid

Semarang 33 58,9 58,9 58,9

Luar Semarang 23 41,1 41,1 100,0

(11)

Frekuensi Alamat Eklampsia

Valid

Semarang 4 25,0 25,0 25,0

Luar Semarang 12 75,0 75,0 100,0

Total 16 100,0 100,0

Frekuensi Alamat Kelompok Kontrol

Valid

Semarang 68 80,0 80,0 80,0

Luar Semarang 17 20,0 20,0 100,0

Total 85 100,0 100,0

Frekuensi Tingkat Pendidikan Preeklampsia Ringan

Valid

Dasar 4 30,8 30,8 30,8

Menengah 9 69,2 69,2 100,0

Total 13 100,0 100,0

FrekuensiTingkat Pendidikan Preeklampsia Berat

(12)

FrekuensiTingkat Pendidikan Kelompok Kontrol

FrekuensiStatus Pekerjaan Preeklampsia Ringan

Valid

Bekerja 1 7,7 7,7 7,7

Tidak Bekerja 12 92,3 92,3 100,0

Total 13 100,0 100,0

FrekuensiStatus Pekerjaan Preeklampsia Berat

Valid

Bekerja 2 12,5 12,5 12,5

Tidak Bekerja 14 87,5 87,5 100,0

Total 16 100,0 100,0

FrekuensiStatus Pekerjaan Kelompok Kontrol

Valid

Primigravida 6 46,2 46,2 46,2 Multigravida 7 53,8 53,8 100,0

(13)

FrekuensiGravida Preeklampsia Berat

Frekuensi Jumlah Paritas Preeklampsia Ringan

Frekuensi Jumlah ParitasPreeklampsia Berat

(14)

Frekuensi Jumlah Paritas Eklampsia

Frekuensi Jumlah Paritas Kelompok Kontrol

Deskripsi Usia Kehamilan Preeklampsia

Usia Kehamilan

Mean 36,25 ,338

95% Confidence Interval for Mean

Lower Bound 35,57

Upper Bound 36,92

Median 37,00

Variance 9,712

Minimum 28

Maximum 42

Range 14

Skewness -,702 ,261

(15)

Deskripsi Usia Kehamilan Kelompok Kontrol

Usia Kehamilan

Mean 38,27 ,259

Lower Bound 37,76

Upper Bound 38,79

Median 39,00

Variance 5,700

Minimum 27

Maximum 42

Range 15

Skewness -1,931 ,261

Kurtosis 5,917 ,517

Frekuensi Usia Kehamilan Preeklampsia Ringan

Frequency Percent Valid Percent Cumulative

Percent

Valid

Prematur ₂ _15,4 _15,4 _15,4

Aterm ₁₁ _84,6 _84,6 _100,0

Total 13 100,0 100,0

FrekuensiUsia Kehamilan Preeklampsia Berat

(16)

FrekuensiUsia Kehamilan Kelompok Kontrol

Frekuensi ANC Preeklampsia Ringan

Valid

<4 4 25,0 25,0 25,0

≥4 12 75,0 75,0 100,0

Total 16 100,0 100,0

Frekuensi ANC Kelompok Kontrol

(17)

FrekuensiRujukan Preeklampsia Berat

Frekuensi Rujukan Kelompok Kontrol

FrekuensiJenis Partus Preeklampsia Ringan

(18)

FrekuensiJenis Partus Preeklampsia Berat

Valid

Bedah Sesar 13 81,3 81,3 81,3

Spontan Pervaginam 3 18,8 18,8 100,0

Total 16 100,0 100,0

FrekuensiJenis Partus Kelompok Kontrol

Frequency Percent Valid Percent Cumulative Percent Valid Spontan Pervaginam 85 100,0 100,0 100,0

Frekuensi BMI Preeklampsia Ringan

Valid

≥25 1 7,7 7,7 7,7

<25 12 92,3 92,3 100,0

Total 13 100,0 100,0

Frekuensi BMI Preeklampsia Berat

(19)

Frekuensi BMI Kelompok Kontrol

Valid

≥25 2 2,4 2,4 2,4

<25 83 97,6 97,6 100,0

Total 85 100,0 100,0

Frekuensi Anemia Preeklampsia Ringan

Frekuensi Anemia Preeklampsia Berat

Frekuensi Anemia Kelompok Kontrol

(20)

Frekuensi Sindroma HELLP Preeklampsi Ringan

Frequency Percent Valid Percent Cumulative Percent Valid Tidak Sindroma HELLP 13 100,0 100,0 100,0

Frekuensi Sindroma HELLP Preeklampsia Berat

Valid

Sindroma HELLP 6 10,7 10,7 10,7

Tidak Sindroma HELLP 50 89,3 89,3 100,0

Total 56 100,0 100,0

Frekuensi Sindroma HELLP Eklampsia

Valid

Sindroma HELLP 1 6,3 6,3 6,3

Tidak Sindroma HELLP 15 93,8 93,8 100,0

Total 16 100,0 100,0

Frekuensi Sindroma HELLP Kelompok Kontrol

Frequency Percent Valid Percent Cumulative Percent Valid Tidak Sindroma HELLP 85 100,0 100,0 100,0

Kejang pada Eklampsia

Frequency Percent Valid Percent Cumulative Percent Valid Kejang 16 100,0 100,0 100,0

Deskripsi Profil Hematologi

Jenis_perlakuan Statistic Std. Error

Eritrosit Eklampsia

Mean 4,3563 ,19205

Lower Bound 3,9469

Upper Bound 4,7656

Median 4,4500

Variance ,590

Std. Deviation ,76821

Minimum 2,20

Maximum 5,62

Range 3,42

Interquartile Range ,61

(21)

Eritrosit

PE Berat

Mean 4,4535 ,06709

Lower Bound 4,3191 Upper Bound 4,5880

Median 4,5000

Variance ,252

Minimum 3,30

Maximum 5,60

Range 2,30

Skewness ,295 ,319

Kurtosis ,147 ,628

PE Ringan

Mean 3,8655 ,14695

Lower Bound 3,5453

Upper Bound 4,1856

Median 3,8000

Variance ,281

Minimum 2,60

Maximum 4,80

Range 2,20

Skewness -,713 ,616

Kurtosis 2,177 1,191

Kontrol

Mean 4,0863 ,04989

Lower Bound 3,9871

Upper Bound 4,1855

Median 4,1000

Variance ,212

Minimum 2,10

Maximum 5,20

Range 3,10

Skewness -,639 ,261

(22)

Hemoglobin

Eklampsia

Mean 12,3500 ,49007

Median 12,8500

Variance 3,843

Minimum 6,30

Maximum 14,30

Range 8,00

Interquartile Range 1,58

PE Berat

Mean 12,4609 ,22712

Lower Bound 12,0057

Upper Bound 12,9161

Median 12,6500

Variance 2,889

Minimum 8,50

Maximum 16,90

Range 8,40

Skewness ,023 ,319

Kurtosis ,327 ,628

PE Ringan

Mean 10,8062 ,47592

Lower Bound 9,7692

Upper Bound 11,8431

Median 10,8000

Variance 2,944

Minimum 7,80

Maximum 13,60

Range 5,80

Skewness ,030 ,616

(23)

Kontrol

Mean 11,5136 ,17949

Lower Bound 11,1567

Upper Bound 11,8706

Median 11,7200

Variance 2,738

Minimum 7,10

Maximum 14,60

Range 7,50

Skewness -,766 ,261

Kurtosis ,320 ,517

Hematokrit

Eklampsia

Mean 36,2188 1,41728

Median 38,5500

Variance 32,139

Minimum 18,60

Maximum 41,30

Range 22,70

PE Berat

Mean 36,5673 ,61608

Lower Bound 35,3327

Upper Bound 37,8020

Median 36,9350

Variance 21,255

Minimum 25,90

Maximum 48,00

Range 22,10

Skewness ,162 ,319

Kurtosis ,408 ,628

(24)

Hematokrit

PE Ringan

Mean 31,9623 1,24425

Lower Bound 29,2513

Upper Bound 34,6733

Median 33,4000

Variance 20,126

Minimum 23,80

Maximum 38,30

Range 14,50

Skewness -,326 ,616

Kurtosis -,928 1,191

Kontrol

Mean 33,5013 ,48095

Median 34,2000

Variance 19,662

Minimum 22,10

Maximum 42,80

Range 20,70

Skewness -,604 ,261

Kurtosis ,190 ,517

MCH Eklampsia

Mean 28,1125 ,74184

Lower Bound 26,5313

Upper Bound 29,6937

Median 28,7000

Variance 8,805

Minimum 23,00

Maximum 33,50

Range 10,50

Skewness -,210 ,564

(25)

PE Berat

Mean 28,1013 ,38351

Lower Bound 27,3327

Upper Bound 28,8698

Median 28,7000

Variance 8,236

Minimum 18,80

Maximum 32,68

Range 13,88

Kurtosis 1,858 ,628

PE Ringan

Mean 28,2331 ,78008

Median 28,5000

Variance 7,911

Minimum 22,40

Maximum 31,90

Range 9,50

Skewness -,789 ,616

Kurtosis ,114 1,191

Kontrol

Mean 28,2878 ,41249

Lower Bound 27,4675

Upper Bound 29,1080

Median 29,0000

Variance 14,462

Minimum 18,70

Maximum 40,90

Range 22,20

Skewness -,412 ,261

Kurtosis 1,174 ,517

(26)

MCV

Eklampsia

Mean 82,9125 1,74052

Median 83,6500

Variance 48,471

Minimum 68,80

Maximum 91,90

Range 23,10

Skewness -,871 ,564

Kurtosis ,014 1,091

PE Berat

Mean 82,2202 ,91094

Lower Bound 80,3946

Upper Bound 84,0457

Median 83,2500

Variance 46,470

Minimum 58,80

Maximum 93,20

Range 34,40

Kurtosis 2,829 ,628

PE Ringan

Mean 83,7623 2,36788

Lower Bound 78,6031

Upper Bound 88,9215

Median 88,5000

Variance 72,889

Minimum 67,60

Maximum 94,00

Range 26,40

Skewness -,684 ,616

(27)

MCV Kontrol

Mean 82,2678 1,04077

Lower Bound 80,1981

Upper Bound 84,3375

Median 84,3000

Variance 92,072

Minimum 58,70

Maximum 118,20

Range 59,50

Skewness -,217 ,261

Kurtosis 1,981 ,517

MCHC

Eklampsia

Mean 33,8563 ,37081

Median 33,7000

Variance 2,200

Minimum 30,60

Maximum 36,50

Range 5,90

Skewness ,047 ,564

Kurtosis ,974 1,091

PE Berat

Mean 34,0146 ,18532

Lower Bound 33,6433

Upper Bound 34,3860

Median 34,1000

Variance 1,923

Minimum 30,30

Maximum 36,50

Range 6,20

Skewness -,524 ,319

(28)

PE Ringan

Mean 33,7600 ,43200

Lower Bound 32,8187

Upper Bound 34,7013

Median 33,9000

Variance 2,426

Minimum 29,70

Maximum 35,60

Range 5,90

Kontrol

Mean 34,3093 ,12284

Median 34,3000

Variance 1,283

Minimum 31,30

Maximum 36,60

Range 5,30

Skewness -,333 ,261

Kurtosis -,078 ,517

Leukosit

Eklampsia

Mean 20,3756 1,81807

Lower Bound 16,5005

Upper Bound 24,2507

Median 20,0500

Variance 52,886

Minimum 10,20

Maximum 31,80

Range 21,60

Skewness ,239 ,564

Kurtosis -1,272 1,091

(29)

PE Berat

Mean 14,5888 ,50729

Median 13,4500

Variance 14,411

Minimum 6,23

Maximum 25,90

Range 19,67

Skewness ,598 ,319

Kurtosis ,394 ,628

PE Ringan

Mean 13,4500 1,03077

Lower Bound 11,2042

Upper Bound 15,6958

Median 13,4000

Variance 13,812

Minimum 8,84

Maximum 20,71

Range 11,87

Skewness ,847 ,616

Kurtosis ,200 1,191

Kontrol

Mean 12,4215 ,34491

Lower Bound 11,7356

Upper Bound 13,1074

Median 12,3000

Variance 10,112

Minimum 6,60

Maximum 23,20

Range 16,60

Skewness ,443 ,261

Kurtosis ,403 ,517

(30)

Trombosit

Eklampsia

Mean 247,3313 26,89517

Lower Bound 190,0056

Upper Bound 304,6569

Median 256,5000

Variance 11573,602

Minimum 51,40

Maximum 420,00

Range 368,60

Skewness -,246 ,564

PE Berat

Mean 223,7782 12,58424

Median 246,9500

Variance 8868,336

Minimum 8,90

Maximum 387,80

Range 378,90

Skewness -,432 ,319

Kurtosis -,354 ,628

PE Ringan

Mean 248,5615 19,39924

Upper Bound 290,8288 5% Trimmed Mean 247,2350

Median 233,1000

Variance 4892,294

Minimum 148,00

Maximum 373,00

Range 225,00

Skewness ,408 ,616

(31)

Kontrol

Mean 254,1165 6,72605

Median 250,0000

Variance 3845,380

Minimum 133,30

Maximum 458,80

Range 325,50

Skewness ,596 ,261

Kurtosis ,341 ,517

Tes Normalitas Data

Kolmogorov-Smirnova Shapiro-Wilk

Statistic df Sig. Statistic df Sig.

*. This is a lower bound of the true significance.

a. Lilliefors Significance Correction

Tes Normalitas Transformasi Data

(32)

Tes Homogenitas Varian Data

Levene Statistic df1 df2 Sig.

Eritrosit ,899 3 166 ,443

Hemoglobin ,018 3 166 ,997

Hematokrit ,086 3 166 ,968

MCH 1,543 3 166 ,205

MCV 2,205 3 166 ,089

MCHC 1,140 3 166 ,334

Leukosit 9,779 3 166 ,000

Trombosit 5,316 3 166 ,002

Tes Homogenitas Varian Transformasi Data

Levene Statistic df1 df2 Sig.

Leukosit ,952 3 166 ,417

Trombosit 7,894 3 166 ,000

Uji One Way ANOVA

Sum of Squares Df Mean Square F Sig.

Eritrosit

Between Groups 6,501 3 2,167 8,201 ,000

Within Groups 43,860 166 ,264

Total 50,361 169

MCHC

Between Groups 6,455 3 2,152 1,296 ,278

Within Groups 275,634 166 1,660

Total 282,089 169

Leukosit

Between Groups 885,268 3 295,089 18,833 ,000

Within Groups 2601,045 166 15,669

(33)

Kruskal-Wallis Test

Ranks

Jenis_perlakuan N Mean Rank

Hemoglobin

Hemoglobin Hematokrit MCH MCV Trombosit

Chi-Square 17,362 22,365 ,714 1,129 2,634

df 3 3 3 3 3

Asymp. Sig. ,001 ,000 ,870 ,770 ,452

a. Kruskal Wallis Test

(34)

Post Hoc Tests

Std. Error Sig. 95% Confidence Interval

Lower Bound Upper Bound

(35)

(36)

Kontrol

Eklampsia -,64474 2,30652 ,780 -5,1986 3,9092

PE Berat ,04759 1,45671 ,974 -2,8285 2,9237

PE Ringan -1,49454 2,52057 ,554 -6,4710 3,4820

MCHC Eklampsia

PE Berat -,15839 ,36528 ,665 -,8796 ,5628

Eklampsia -23,55304 22,47074 ,296 -67,9183 20,8122

(37)

Kontrol -30,33826* 13,64304 ,028 -57,2745 -3,4020

PE Ringan

Eklampsia 1,23029 29,59869 ,967 -57,2081 59,6687

PE Berat 24,78332 24,40417 ,311 -23,3992 72,9659

Kontrol -5,55493 23,60680 ,814 -52,1632 41,0533

Kontrol

Eklampsia 6,78522 21,60212 ,754 -35,8651 49,4355

PE Berat 30,33826* 13,64304 ,028 3,4020 57,2745

PE Ringan 5,55493 23,60680 ,814 -41,0533 52,1632

*. The mean difference is significant at the 0.05 level.

Deskripsi Hemogbin dan Berat Bayi Lahir

Hemoglobin

Mean 1,0684 ,00536

Mean

Lower Bound 1,0578

Upper Bound 1,0790

Median 1,0810

Variance ,005

Minimum ,80

Maximum 1,23

Range ,43

Kurtosis 1,656 ,370

BBL

Mean 3,4224 ,01175

Mean

Lower Bound 3,3992

Upper Bound 3,4456

(38)

Variance ,023

Minimum 2,54

Maximum 3,66

Range 1,12

Kurtosis 8,192 ,370

Tes Normalitas Hemogbin dan Berat Bayi Lahir

Statistic Df Sig. Statistic df Sig.

Hemoglobin ,084 170 ,005 ,975 170 ,004

BBL ,118 170 ,000 ,961 170 ,000

Tes Normalitas Transformasi Hemogbin dan Berat Bayi Lahir

Hemoglobin ,116 170 ,000 ,934 170 ,000

BBL ,170 170 ,000 ,799 170 ,000

Uji Korelas Spearman

Hemoglobin BBL

Hemoglobin

Pearson Correlation 1 -,269**

Sig. (2-tailed) ,000

N 170 170

BBL

Pearson Correlation -,269** 1

Sig. (2-tailed) ,000

N 170 170

(39)

(40)